3

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Aug 12, 2022
Document Date
Aug 8, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
RVL Pharmaceuticals
Issuer
RVL PHARMACEUTICALS PLC
Filer
ATHYRIUM OPPORTUNITIES IV ACQUISITION 2 LP